Tag: tumor perfusion
-
Can IVIM MRI outpace ADC in predicting aggressive endometrial carcinoma subtypes under FIGO 2023 guidance? New imaging insights
Introduction: IVIM MRI and the FIGO 2023 framework Endometrial carcinoma (EC) remains a leading gynecologic cancer worldwide, with rising incidence and diverse histological subtypes. The FIGO 2023 classification emphasizes prognosis based on biological behavior, separating tumors into aggressive and non-aggressive groups. Magnetic resonance imaging (MRI) has long been the backbone of preoperative assessment, balancing anatomical…